Rare Community Profiles: Shantel S. and Shriners Children’s are Transforming the Way We Understand Arthrogryposis Multiplex Congenita (AMC)
https://pixabay.com/en/book-heart-love-grains-sand-sea-2115176/

Rare Community Profiles: Shantel S. and Shriners Children’s are Transforming the Way We Understand Arthrogryposis Multiplex Congenita (AMC)

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Shantel S. and Shriners Children’s are Transforming the Way We Understand Arthrogryposis Multiplex Congenita (AMC)
RP-A601 Granted Orphan Drug and Fast Track Designations for Rare Cardiomyopathy
source: pixabay.com

RP-A601 Granted Orphan Drug and Fast Track Designations for Rare Cardiomyopathy

  Gene therapy has the potential to improve outcomes among individuals across various disease spectrums. In the case of clinical-stage biotechnology company Rocket Pharmaceuticals, the company is working to develop…

Continue Reading RP-A601 Granted Orphan Drug and Fast Track Designations for Rare Cardiomyopathy

Enrollment Complete in ARO-APOC3 Trial for Familial Chylomicronemia Syndrome

  Right now, there are insufficient treatment options for familial chylomicronemia syndrome (FCS). Unfortunately, this means that individuals living with this rare genetic disease are left without much assistance. The…

Continue Reading Enrollment Complete in ARO-APOC3 Trial for Familial Chylomicronemia Syndrome
They Don’t Know What They Don’t Know: Learning to Manage Judgement and Criticism from Others When Living with a Chronic and Debilitating Condition
source: shutterstock.com

They Don’t Know What They Don’t Know: Learning to Manage Judgement and Criticism from Others When Living with a Chronic and Debilitating Condition

Written by Lisa Matthews I know I am not alone in my suffering…Recently, I read an article published in 2018 by The National Library of Medicine where it was estimated that,…

Continue Reading They Don’t Know What They Don’t Know: Learning to Manage Judgement and Criticism from Others When Living with a Chronic and Debilitating Condition
FDA Lifts Clinical Hold on Phase 1 AML and MDS Clinical Trial
source: pixabay.com

FDA Lifts Clinical Hold on Phase 1 AML and MDS Clinical Trial

Effective June 1, 2023, the FDA lifted its clinical hold on Foghorn Therapeutics’ Phase 1 study of FHD-286 dose escalation in patients with acute myeloid leukemia and myelodysplastic syndromes. The…

Continue Reading FDA Lifts Clinical Hold on Phase 1 AML and MDS Clinical Trial
Potential Link Exists Between Gut Microbiota Imbalance and Machado-Joseph Disease (MJD)
qimono / Pixabay

Potential Link Exists Between Gut Microbiota Imbalance and Machado-Joseph Disease (MJD)

  Past studies have shown that our gut microbiota, or the collection of microorganisms (bacteria, archaea, fungi, yeast, viruses) within our gut, plays an immense role in our health. Our…

Continue Reading Potential Link Exists Between Gut Microbiota Imbalance and Machado-Joseph Disease (MJD)
Rare Community Profiles: Probably Genetic Offers No-Cost Genetic Testing for Rare Diseases: A Conversation with CEO Lukas Lange
source: shutterstock.com

Rare Community Profiles: Probably Genetic Offers No-Cost Genetic Testing for Rare Diseases: A Conversation with CEO Lukas Lange

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Probably Genetic Offers No-Cost Genetic Testing for Rare Diseases: A Conversation with CEO Lukas Lange